DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Florbetaben f-18is the generic ingredient in one branded drug marketed by Life Molecular and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.
Florbetaben f-18 has thirty-four patent family members in twenty-six countries.
One supplier is listed for this compound.
Recent Clinical Trials for FLORBETABEN F-18
Identify potential brand extensions & 505(b)(2) entrants
|University of Pennsylvania||Early Phase 1|
|Central Hospital, Nancy, France||Phase 2/Phase 3|
|Seoul National University Hospital||Phase 3|
Pharmacology for FLORBETABEN F-18
|Drug Class||Radioactive Diagnostic Agent |
|Mechanism of Action||Positron Emitting Activity |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Life Molecular||NEURACEQ||florbetaben f-18||SOLUTION;INTRAVENOUS||204677-001||Mar 19, 2014||RX||Yes||Yes||Start Trial||Start Trial||Y||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2213652||C02213652/01||Switzerland||Start Trial||PRODUCT NAME: FLORBETABEN (18F); REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66210 23.08.2017|
|2213652||92647||Luxembourg||Start Trial||PRODUCT NAME: FLORBETABEN (18F). FIRST REGISTRATION: 20140224|
|2213652||CR 2015 00018||Denmark||Start Trial||PRODUCT NAME: FLORBETABEN (18F); REG. NO/DATE: EU/1/13/906/001 20140224|
|2213652||1590005-3||Sweden||Start Trial||PRODUCT NAME: FLORBETABEN (18F); REG. NO/DATE: EU/1/13/906 20140224|
|2213652||8/2015||Austria||Start Trial||PRODUCT NAME: FLORBETABEN (18 F); REGISTRATION NO/DATE: EU/1/13/906/001 (MITTEILUNG) 20140224|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.